Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2487216 | Journal of Pharmaceutical Sciences | 2009 | 9 Pages |
Abstract
The interaction between cationic porphyrin, a potential valuable anti-tumor and antibiotic drug, and human serum albumin (HSA) was investigated using spectroscopy methods. The binding constants were obtained using fluorescence quenching method (KSVâ=â(3.24â±â0.29)âÃâ104 Mâ1) and surface plasmon resonance (SPR) spectroscopy (KAâ=â(6.287â±â0.407)âÃâ104 Mâ1). The association rate constant (kaâ=â1622â±â72.9 Mâ1âsâ1) and dissociation rate constant (Kdâ=â0.02589â±â0.0024 sâ1) of the binding process were also calculated. Compared with the two results, it was known that one of the binding sites was near the tryptophan residue and also there existed other binding sites. The Fourier transform infrared (FT-IR) spectroscopy and circular dichroism (CD) spectroscopy indicated that the confirmation of HSA was nearly not affected with the addition of porphyrin. © 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:105-113, 2009
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Drug Discovery
Authors
Bo Zhou, Zhi Zhang, Yue Zhang, Ran Li, Qi Xiao, Yi Liu, ZaoYing Li,